Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.21
P/E—
Fwd P/E16.66
PEG1.20
52W— – —
RSI—
Target$270.94 (+15.5%)
Beta0.52
Div0.87%
Loading chart…
RSI ()
Loading patterns…
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 47
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
5Bullish
3Bearish
0Neutral
Momentum Signals 8
▲ MACD Bullish Crossover
▲ Bull Flag
▲ Bull Flag
▲ MACD Bullish Crossover
No major reversal patterns in the last 4 months — showing momentum signals only.
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
STRONG BUY
BuyHoldSell
Price Target Range
$270.94
+15.5% upside
Low $235
—
High $292
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
3.84%Last 12 Months
Operating Margin
1.33%Last 12 Months
Return on Equity
N/ALast 12 Months
Revenue Growth
5.80%Year over Year
Free Cash Flow
4.75BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
N/AMost Recent Quarter
Current Ratio
0.88Most Recent Quarter
Cash
4.86BMost Recent Quarter
Total Debt
10.00BMost Recent Quarter
Net Debt
—Most Recent Quarter
How CAH Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 54.56B |
| Enterprise Value | 59.86B |
| Trailing P/E | 32.67 |
| Forward P/E | 16.66 |
| PEG Ratio (5yr) | 1.20 |
| Price/Sales (ttm) | 0.21 |
| Price/Book (mrq) | -18.96 |
| EV/Revenue | 0.23 |
| EV/EBITDA | 14.10 |
Share Statistics
| Avg Vol (3m) | 2.07M |
| Shares Outstanding | 232.58M |
| Float | 232.04M |
| % Held by Insiders | 0.27% |
| % Held by Institutions | 91.04% |
| Short Ratio | 3.62 |
| Short % of Float | 3.34% |
Profitability
| Gross Margin | 3.84% |
| Operating Margin (ttm) | 1.33% |
| Profit Margin | 0.67% |
| Return on Assets (ttm) | 3.72% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 254.25B |
| Revenue Growth (yoy) | 5.80% |
| Gross Profit (ttm) | 9.77B |
| EBITDA | 4.24B |
| Net Income (ttm) | 1.71B |
| Diluted EPS (ttm) | 7.18 |
| EPS Growth (yoy) | 68.80% |
Balance Sheet
| Total Cash (mrq) | 4.86B |
| Total Debt (mrq) | 10.00B |
| Debt / Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.88 |
| Book Value / Share | -12.37 |
| Operating CF (ttm) | 5.17B |
| Free Cash Flow (ttm) | 4.75B |
Trading & Dividends
| Beta (5Y) | 0.52 |
| 50-Day MA | 234.32 |
| 200-Day MA | 216.23 |
| Fwd Dividend Yield | 0.87% |
| Payout Ratio | 28.33% |
Income
Dividend Yield
0.87%Last 12 Months
Annual Rate
2.06Forward
Payout Ratio
28.33%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 28.33%
Monthly Dividends
Ownership Breakdown
Institutional 91.04%
Insider 0.27%
Public 8.7%
Short Interest
3.34% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in CAH in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|